Edition:
United Kingdom

Cellular Biomedicine Group Inc (CBMG.OQ)

CBMG.OQ on NASDAQ Stock Exchange Global Market

18.30USD
17 May 2018
Change (% chg)

-- (--)
Prev Close
$18.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,257
52-wk High
$22.75
52-wk Low
$5.50

Latest Key Developments (Source: Significant Developments)

Cellular Biomedicine Announces Plan To Configure Part Of Shanghai Facility
Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Cellular Biomedicine Group Inc ::CELLULAR BIOMEDICINE GROUP INC - ANNOUNCED PLAN TO CONFIGURE PART OF ITS FACILITY IN SHANGHAI WITH GE HEALTHCARE'S FLEXFACTORY PLATFORM.CELLULAR BIOMEDICINE-AFTER EXECUTION OF NON-BINDING LOI, SEES FLEXFACTORY TO BE OPERATIONAL IN CBMG-GE JOINT LABORATORY OF CELL THERAPY BY END OF 2018.  Full Article

Cellular Biomedicine Group reports qtrly ‍loss per share $0.43
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Cellular Biomedicine Group Inc :Cellular Biomedicine Group reports third quarter financial results and recent operational highlights.Cellular Biomedicine Group Inc- ‍$16.3 million cash and cash equivalents as of September 30, 2017 as compared to $27.3 million as of June 30, 2017​.Cellular Biomedicine Group Inc - Qtrly ‍loss per share $0.43​.Cellular Biomedicine Group Inc - Qtrly net sales and revenue $106,787 versus $10,012‍​.  Full Article

Thermo Fisher Scientific and Cellular Biomedicine announce partnership to develop manufacturing processes
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Cellular Biomedicine Group Inc :Thermo Fisher Scientific and Cellular Biomedicine Group announce strategic partnership to develop manufacturing processes.Cellular Biomedicine Group Inc - ‍partnership focuses on research and development of an automated cell therapy manufacturing system​.  Full Article

Cellular Biomedicine Group announces resale of up to 5.1 mln shares of common stock for sale by selling stockholders
Monday, 20 Jun 2016 

Cellular Biomedicine Group Inc :Resale of up to 5.1 million shares of common stock for sale by the selling stockholders - SEC filing.  Full Article

BRIEF-Cellular Biomedicine Group Qtrly Loss Per Share $0.51

* CELLULAR BIOMEDICINE GROUP REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS